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Diabetic myonecrosis is a rare, self-limited complication of poorly controlled diabetes mellitus (DM) that commonly presents with acute, intense pain and swelling of the lower extremities, with the thigh being the most commonly affected area, and responds well to conservative management. 3 Notably, this case is unique in that it represents the first report of diabetic myonecrosis in an adult patient with CF. Adults with CF are a small but growing patient population due to increased survival. In 1991, over 32% of people in the United States Cystic Fibrosis Foundation Patient Registry were ages 18 years or older. This percentage increased to more than 48% in 2011. The registry contained 27,111 patients with CF in 2011, of whom 13,094 were adults. 4 The median age of survival of patients with CF is now into the late 30s.This presents providers of adult CF patients with new challenges in managing these patients. There is a need for additional information in diagnosing and treating these patients in the inpatient and outpatient settings where they may report with acute singularly unique presentations, as this case illustrates.
Recognizing that CFRD can occur in adults with CF is important, because adults with CF have a tendency to develop CF-related arthropathy, 5 which is more likely to be suspected when these patients present with lower extremity pain. Diabetic myonecrosis is not currently included among differential diagnoses in patients with CF, because it has never been reported in CFRD patients before, and yet it is important that this diagnosis not be missed. Although biopsy is the gold standard for a definitive diagnosis of diabetic myonecrosis, no biopsy was performed on the patient because it was not in the clinical best interest of the patient for the following reasons. The patient described in this case report had undergone a bilateral lung transplant consequential to underlying cystic fibrosis. Because of his transplantation status, he was on chronic immunosuppressant medication. Furthermore, with an HbA1C of 10.3%, his risk for poor wound healing and infection were increased. The increased risks for complications including impaired wound-healing and hemorrhage, 6 prompted a cautionary approach to consideration of undertaking muscle biopsy. While lack of a confirmatory biopsy is a limitation of this report, the MRI findings were sufficiently robust to support the diagnosis.
Conservative management was initiated, with treatment including complete bed rest, analgesics, an antiplatelet agent, aspirin 81 mg/day, and adequate glycemic control. Physical therapy was specifically avoided. The patient reported significant improvement in symptoms within the 3-day period of hospitalization. He was off crutches within a week and completely pain-free by 4 weeks post-discharge.
Discussion
In patients with CF, CFRD is a common comorbidity with prevalence as high as 50% in adult patients, increasing with age.
exhibited in CFRD, and it is primarily caused by underlying insulin insufficiency, although insulin resistance related to acute or chronic illness may play a role. While the pathogenesis of diabetic myonecrosis remains unclear, atheroembolism of the small vessels has been proposed. 11 However, since the genetic defect in cystic fibrosis leads to malabsorption of fats, cystic fibrosis patients generally exhibit low total and low density lipoprotein (LDL) cholesterol. Given the low cholesterol levels in our patient, atheroembolism of the small vessels as a pathogenic mechanism seems unlikely. Furthermore, despite low total cholesterol and LDL levels, the patient had developed microvascular disease (diabetic nephropathy and peripheral neuropathy), suggesting that microvascular disease may not be as dependent upon atherosclerosis in this group of patients. An alternative mechanism proposed for diabetic myonecrosis includes underlying abnormalities in the clotting cascade or fibrinolytic pathway, although this has not been well elucidated. The fact that cystic fibrosis patients can develop diabetic myonecrosis while presenting with a history of low cholesterol levels suggests that further research is warranted in elucidating mechanism(s) underlying this complication of diabetes. Furthermore, the patient exhibited high levels of inflammatory markers (CRP was 8.6
and ESR 66). This pro-inflammatory state, along with his unusually poor diabetic control (HbA1C of 10.3%) may have played a role in the pathogenesis of diabetic myonecrosis in this patient.
In our patient, poor control of his diabetes was likely exacerbated by continuation of steroidal treatment necessitated by the lung transplantation in 2008. In this context, diabetic myonecrosis has been reported in patients with orthotopic heart transplant 12 and islet cell transplant 10 and was attributed to emergent diabetes which developed consequential to immunosuppressive treatment. 13 It is not certain how common diabetic myonecrosis is in transplanted patients. In our review of the literature using the MeSH term 'diabetic myonecrosis' we found only 2 reports Exhibiting features of both type 1 and type 2 diabetes, CFRD is associated with decreased insulin production and increased insulin resistance. Although the primary contributing defect is decreased production of insulin due to destruction of beta cells, emerging insulin resistance is initially the main stimulus of CFRD, secondary to acute infections. Affected patients exhibit decreased peripheral glucose uptake and poor insulin suppression of hepatic glucose production which concomitantly increases insulin resistance. 14 Patients with CFRD have poorly controlled diabetes in general because of malabsorption and consequential high caloric needs associated with an underlying deficiency in pancreatic enzymes, leading to abnormalities in bile salts, mucosal transport problems, and variance in motility.
The imaging modality of choice for soft tissue evaluation is MRI, which shows findings of increased signal on T2 imaging in patients presenting with edema and no discrete masses.
Although tissue biopsy can be used to confirm the diagnosis , it is not required for diagnosis, since MRI and a thorough clinical evaluation are generally sufficient. 7 In the case of our patient who was being treated with immunosuppressive medication, biopsy was not pursued since the 
